Biogen expects $164M R&D charge to hit Q2 2026 earnings

Go back to Biogen expects $164M R&D charge to hit Q2 2026 earnings
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 223.30 -2.06 (0.91%)
Previous Close $225.36    52 Week High $333.65 
Open $226.94    52 Week Low $223.02 
Day High $229.19    P/E 28.59 
Day Low $222.36    EPS $7.81 
Volume 398,384